(Q60718626)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Suppression of tumor necrosis factor-alpha production by interleukin-10 is enhanced by cAMP-elevating agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Gunther Hartmann

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

6

S Endres

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

A Eigler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

J Moeller

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

T F Greten

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

English

0 references

publication date

1 February 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063693%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

321

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

231-239

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063693%20AND%20SRC:MED&resulttype=core&format=json

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

Macrophage deactivation by interleukin 10

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

Tumor necrosis factor type alpha stimulates human endothelial cells to produce granulocyte/macrophage colony-stimulating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

Endogenous adenosine curtails lipopolysaccharide-stimulated tumour necrosis factor synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

Prostacyclin analogs suppress the synthesis of tumor necrosis factor-alpha in LPS-stimulated human peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

Measurement of immunoreactive interleukin-1 beta from human mononuclear cells: optimization of recovery, intrasubject consistency, and comparison with interleukin-1 alpha and tumor necrosis factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

Cicaprost and the type IV phosphodiesterase inhibitor, rolipram, synergize in suppression of tumor necrosis factor-alpha synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

Interleukin 10 protects mice from lethal endotoxemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

Differential effects of IL-4 and IL-10 on IL-2-induced IFN-γ synthesis and lymphokine-activated killer activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

Effect of tumor necrosis factor alpha on mitogen-activated human B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

The cooperative effects of TNF-alpha and IFN-gamma are determining factors in the ability of IL-10 to protect mice from lethal endotoxemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

Identification of a novel thymocyte growth-promoting factor derived from B cell lymphomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

Tumor necrosis factor: a pleiotropic cytokine and therapeutic target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

Concentrations of immunoreactive human tumor necrosis factor alpha produced by human mononuclear cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900947-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(96)00947-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference